News & Perspectives
Save the Date: EU/UK Medical Device & IVD Bootcamp
Join us on Tuesday, 9 June 2026 for a full day bootcamp into the world of medical devices and IVDs! We will discuss the details you need to know, the current EU and UK regulatory landscape, and hot topics.
Congress Considers Broad PFAS Legislation Targeting Nonessential Uses and Environmental Releases
Congress is considering legislation that could significantly expand federal regulation of per- and polyfluoroalkyl substances (PFAS), particularly in consumer products. If enacted, the legislation could move toward a national framework that partially aligns with and extends beyond certain recent state-level PFAS-in-products programs.
Virtual and Digital Health Digest
This digest covers key virtual and digital health regulatory and public policy developments during February and early March 2026 from the United States, United Kingdom, and European Union.
FinCEN Proposes Rule on AML Whistleblower Program
FinCEN’s newly proposed rule marks a major step toward fully implementing its long-awaited AML whistleblower program, introducing financial incentives and enhanced protections for individuals reporting illicit finance violations. This Advisory breaks down the proposal’s key features, including award eligibility, reporting procedures, and compliance implications, and what they mean for financial institutions and potential whistleblowers.